Purchase Order 36C77026P0048
- Not listed
- This is a $42,508.80 firm-fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 15 to Hygen Pharmaceuticals Inc., a minority-owned small business in Redmond, Washington. The contract is set aside for small businesses and covers the supply of various pharmaceutical products, including thyroid medications, acamprosate tablets, dextrose solutions, ophthalmic solutions, and other prescription drugs, to multiple VA Consolidated Mail Outpatient...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,655.82, with completion scheduled for July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Armodafinil is a wakefulness-promoting agent commonly used to treat narcolepsy, obstructive...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Armodafinil 250mg (30-count packages) with a ceiling value of $1,696.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a ceiling value of $5,574.50. This is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, representing a child contract under AmerisourceBergen's broader pharmaceutical supply agreements. The award was made through open competition with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Armodafinil 250 mg tablets (30-count) under a firm fixed-price contract with a ceiling value of $2,910.87. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- The Department of Defense awarded a delivery order valued at $13,777.20 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain and represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a ceiling value of $2,191.50. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025. The award was made through open competition with no set-aside designation, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $5,649.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on November 3, 2025, with completion scheduled for November 4, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The place of performance is AmerisourceBergen's...
- This is a $4,422.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 27, 2025. While the contract was not set aside for a specific business type, Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets in quantities of 30 under a firm fixed price contract valued at $2,217.64. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025. This is a competitive award with no set-aside designation, and performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a...
The Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a $66.8K firm fixed-price purchase order to Hygen Pharmaceuticals Inc., a minority-owned small business based in Redmond, Washington, for the supply of Armodafinil 30-count controlled substance tablets. The contract, which carries a total small business set-aside designation, has an ultimate completion date of March 10, 2026, with performance to be executed in Redmond, Washington. Hygen Pharmaceuticals, an SBA-certified 8(a) Program participant and self-certified small disadvantaged business, is well-positioned to fulfill this requirement given its established track record supplying pharmaceutical products to VA facilities across multiple Veterans Integrated Service Networks. This purchase order supports the VA's Consolidated Mail Outpatient Pharmacy network, which distributes medications to veterans across the country. The award follows a pre-solicitation notice issued by VISN 15's National CMOP Contracting Office seeking Armodafinil tablets in both 250mg and 200mg formulations in 30-count bottles for delivery to its South Carolina facility. As a controlled substance procurement, this contract represents part of the VA's broader pharmaceutical supply chain operations, where Hygen Pharmaceuticals has demonstrated capability through previous awards involving diverse prescription medications delivered to VA CMOP facilities nationwide. The company's SABA 8(a) certification expired on March 9, 2025, which may affect future contract eligibility.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--766_Pharmaceuticals_VA CMOP Charleston A_36C77026Q0080 ARMODAFINIL 30CT CONTROLLED SUBSTANCE | 36C77026Q0080 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Solicitation 2/3 | 1/26/26, 3:09 PM | |
6505--766_Pharmaceuticals_VA CMOP Charleston A_36C77026Q0080 | 36C77026Q0080 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Award Notice 3/3 | 3/10/26, 1:44 PM | |
6505--766_Pharmaceuticals_VA CMOP Charleston A_36C77026Q0080 ARMODAFINIL 30CT CONTROLLED SUBSTANCE | 36C77026Q0080 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Pre-Solicitation 1/3 | 1/26/26, 3:08 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.8k | 3/9/26 |